English
Spanish
French
Italian
German
NEWS ARCHIVE
Explore our archive of news and updates from the HS Foundation — a curated collection of stories, milestones, and announcements from over the years.
Why HS Is So Often Misdiagnosed, With Steven Daveluy, M.D.
Yesterday
Many people with Hidradenitis Suppurativa (HS) suffer in silence — not because the disease is rare, but because it’s too often misunderstood. In a revealing interview, Dr. Steven Daveluy uncovers the myths, missed signals and clinical blind spots that delay diagnosis and care.
Read more
Danby Research Grant Supports New Insights into HS
November 18, 2025
Support from the HS Foundation’s Danby Research Grant enabled Dr. Fang’s work examining the cellular mechanisms involved in HS. Her findings are helping to clarify how immune structures form in the skin and may inform future targeted treatment approaches.
Read more
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
November 16, 2025
Pain, stigma, and delays still too often define the journey for patients with Hidradenitis Suppurativa (HS). This feature HSF leader, Dr. Gretchen Roth, in the Dermatologist offers dermatologists a roadmap to turn HS visits into moments of trust-building, actionable care, and real hope. From empathetic communication to tailored management strategies, learn how one clinic’s compassion driven approach can reshape outcomes for this complex condition.
Read more
Surgical Collaboration Strengthens HS Outcomes Across Disease Stages
November 4, 2025
Surgery is not just a last resort for Hidradenitis Suppurativa (HS) anymore. New collaborative models between dermatologists, surgeons and researchers are transforming outcomes across all disease stages, from localized cases to advanced disease. Discover how this multidisciplinary shift is redefining HS treatment.
Read more
Alexa Kimball, MD, on the Future of HS Care
October 22, 2025
Dr. Alexa Kimball shares insights on the future of hidradenitis suppurativa care — from earlier diagnosis and better treatment strategies to integrating comorbidities into research. She also explores emerging therapies like GLP-1 receptor agonists and what’s next for advancing HS management.
Read more
Recognizing HS: From First Signs to an Accurate Diagnosis
October 16, 2025
Hidradenitis suppurativa is often misunderstood and underdiagnosed—even though its telltale signs can emerge early. Explore how key symptoms like painful nodules, abscesses, and draining tunnels can offer a pathway to timely diagnosis and more compassionate, effective care.
Read more
Beyond the Surface: October 2025
October 10, 2025
This month’s newsletter features exciting updates on the new HS Buddy Program, details for SHSA 2025 in Nashville, current grant opportunities, and the latest HS in the News. Don’t miss what’s happening in the HS community — check it out now!
Read more
Can Quitting Smoking Lower the Risk of Hidradenitis Suppurativa?
September 29, 2025
A new study of more than 6 million people shows that quitting smoking can cut the risk of hidradenitis suppurativa by about one-third—but the benefits appear only after staying smoke-free for at least three years. Relapsing, however, brings the risk right back up.
Read more
HS Summit Spotlights Gaps in Diagnosis and Care
September 11, 2025
The summit highlighted the challenges of diagnosing HS, emphasizing the need for awareness & recognizing chronic, recurrent patterns. Patient storytelling & joint panels underscored the real-world burden of HS & the importance of early intervention. Collaboration between patients & providers is crucial for improving outcomes & raising the standard of care in HS management.
Read more
HS Foundation Launches New HS Buddy Program to Support Clinical Trial Participants
July 29, 2025
The HS Buddy Program is a peer support initiative designed to connect individuals currently in or considering a clinical trial with experienced "buddies" who can offer guidance, share personal insights, and help navigate the clinical trial journey. Learn how you can get involved as a participant or a peer mentor.
Read more
From the Heart: July 2025
July 17, 2025
In this issue: We're celebrating 20 years of advancing care, research, and support for those impacted by Hidradenitis Suppurativa. Catch up on recent news in the HS world, important updates for SHSA 2024 (including early bird deadlines), new research opportunities, and ways to get involved in our growing community.
Read more
New Study Explores Tunnel-Targeted Antimicrobial Gel for HS Treatment
July 11, 2025
A newly published prospective study in JAAD highlights a novel approach for treating Hidradenitis Suppurativa using a topical clindamycin gel delivered directly into tunnels. The treatment showed promising results in reducing inflammation, resolving tunnels, restoring microbial balance, and improving quality of life. Led by researchers at the University of Miami, including HSF President Dr. Hadar Lev-Tov, this work offers new insights into localized therapies for HS.
Read more
Dermatologic Procedures for Hidradenitis Suppurativa
July 10, 2025
Explore how dermatologic procedures like deroofing, excision, and laser therapies are helping patients with hidradenitis suppurativa achieve better outcomes. This article highlights expert insights on selecting the right approach based on severity, recurrence, and patient goals.
Read more
Efficacy and Safety of Medical Interventions for Moderate to Severe Hidradenitis Suppurativa
July 2, 2025
A newly published living systematic review and network meta-analysis in JAMA Dermatology offers an in-depth look at the current evidence on medical therapies for HS. This important research helps inform treatment decisions and highlights the growing momentum in HS clinical trials.
Read more
Best practice in the management of Hidradenitis Suppurativa lesions
July 1, 2025
Access the Best Practice in the Management of Hidradenitis Suppurativa Lesions—an international consensus document offering practical, evidence-informed guidance on diagnosing, assessing & managing HS lesions. Developed by a panel of wound care & dermatology experts, this resource covers cleansing, dressing selection, pain control, surgical options & more.
Read more
Spironolactone for Hidradenitis Suppurativa: A Game-Changer for Women of Childbearing Age?
June 30, 2025
Could spironolactone be a game-changer for women with early-stage HS? A recent study found that while only 1 in 5 women of childbearing age saw improvement with the hormone-blocking drug, those with milder disease and earlier treatment were far more likely to benefit. This research offers valuable insight into tailoring HS treatment for patients most likely to respond.
Read more
Deroofing – Safe and Effective for HS Patients
June 18, 2025
A new study highlights the safety and effectiveness of deroofing—a surgical treatment for hidradenitis suppurativa. Among 44 patients, only 12% of lesions returned within a year, and most reported less pain and better quality of life. While further research is needed, these results suggest deroofing may be a valuable option, even alongside systemic therapies.
Read more
Semaglutide for diabetes, weight loss, and… Hidradenitis Suppurativa?
April 28, 2025
Could a popular weight loss and diabetes drug also help treat hidradenitis suppurativa? See what researchers discovered about semaglutide’s surprising potential.
Read more
Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis Suppura
March 18, 2025
Incyte announced positive Phase 3 results for povorcitinib in hidradenitis suppurativa, with both trials meeting their primary endpoint of reducing inflammatory nodules.
Read more
2025 Danby Research Grant Recipients
March 7, 2025
From machine learning and gene expression to fibroblast signaling and pain pathways, this year’s Danby grantees are advancing bold new investigations into the biology and complexity of Hidradenitis Suppurativa.
Read more